Jill DeSimone
CIK 1930479 · last filed 2025-06-27
Jill DeSimone is a corporate insider who has filed 12 SEC Form 4 insider transactions across 4 companies since 2022. The most recent filing, for PRAX, was dated Jun 27, 2025. Across all open-market trades the lifetime net is +$25.4K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $3.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.87M
4
12
$25.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PRAX | Director | 14,500 | $266.58 | $3.87M | $25.4K | 5 | 2025-06-27 |
| Oncternal Therapeutics, Inc. (ONCT) Delisted | Director | — | $0.53 | — | $0 | 3 | 2024-06-24 |
| iTeos Therapeutics, Inc. (ITOS) Delisted | Director | — | $10.15 | — | $0 | 2 | 2024-06-13 |
| Kinnate Biopharma Inc. (KNTE) Delisted | Director | — | $2.65 | — | $0 | 1 | 2023-03-03 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-27 | PRAX | Grant (A) | — | $0 | EDGAR |
| 2024-06-24 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-13 | iTeos Therapeutics, Inc. (ITOS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-06 | PRAX | Grant (A) | — | $0 | EDGAR |
| 2024-04-05 | — | Disp (D) | — | $0 | |
| 2024-03-07 | iTeos Therapeutics, Inc. (ITOS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-10-10 | PRAX | Buy (P) | +14,500 | $25.4K | EDGAR |
| 2023-06-30 | Oncternal Therapeutics, Inc. (ONCT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-14 | PRAX | Grant (A) | — | $0 | EDGAR |
| 2023-03-03 | Kinnate Biopharma Inc. (KNTE) Delisted | Grant (A) | — | $0 | EDGAR |